• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠系膜静脉与外周静脉血浆中MIR-21的差异表达:一项关于手术切除结肠癌患者无病生存期的观察性研究

Differential MIR-21 expression in plasma from mesenteric versus peripheral veins: an observational study of disease-free survival in surgically resected colon cancer patients.

作者信息

Monzo Mariano, Martínez-Rodenas Francisco, Moreno Isabel, Navarro Alfons, Santasusagna Sandra, Macias Ismael, Muñoz Carmen, Tejero Rut, Hernández Raquel

机构信息

From the Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona (MM, AN, SS, IM, CM, RT); Department of Medical Oncology and Surgery, Hospital Municipal de Badalona, Badalona, Spain (FM-R, IM, RH).

出版信息

Medicine (Baltimore). 2015 Jan;94(1):e145. doi: 10.1097/MD.0000000000000145.

DOI:10.1097/MD.0000000000000145
PMID:25569638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4602834/
Abstract

Findings on the role of plasma miR-21 expression in colorectal cancer are contradictory. Before reaching a peripheral vein (PV), microRNAs released by the tumor are dispersed throughout the body. We hypothesized that blood drawn from the mesenteric vein (MV) near the site of the primary tumor could provide more homogeneous information than blood drawn from the PV.We have analyzed miR-21 expression in matched samples of tumor tissue, normal tissue, MV plasma, and PV plasma in 57 surgically resected patients with colon cancer and correlated our findings with clinical characteristics and disease-free survival (DFS).miR-21 expression was higher in MV than PV plasma (P = 0.014) and in tumor than in normal tissue (P < 0.001). Patients with high levels of miR-21 in MV plasma had shorter DFS (P = 0.05) than those with low levels, and those with high levels in both MV and PV plasma had shorter DFS than all other patients (P = 0.01).Our findings suggest that the primary tumor in colon cancer releases high concentrations of miR-21 in the MV but that these concentrations are later diluted in the circulatory system. MV expression of miR-21 may be a stronger prognostic marker than PV expression.

摘要

关于血浆miR - 21表达在结直肠癌中的作用,研究结果相互矛盾。在进入外周静脉(PV)之前,肿瘤释放的微小RNA会散布于全身。我们推测,从原发性肿瘤部位附近的肠系膜静脉(MV)抽取的血液可能比从PV抽取的血液提供更一致的信息。我们分析了57例接受手术切除的结肠癌患者肿瘤组织、正常组织、MV血浆和PV血浆的配对样本中miR - 21的表达情况,并将我们的研究结果与临床特征和无病生存期(DFS)相关联。miR - 21在MV中的表达高于PV血浆(P = 0.014),在肿瘤组织中的表达高于正常组织(P < 0.001)。MV血浆中miR - 21水平高的患者DFS短于水平低的患者(P = 0.05),MV和PV血浆中miR - 21水平均高的患者DFS短于所有其他患者(P = 0.01)。我们的研究结果表明,结肠癌的原发性肿瘤在MV中释放高浓度的miR - 21,但这些浓度随后在循环系统中被稀释。miR - 21在MV中的表达可能比在PV中的表达是更强的预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b162/4602834/3b944fd13b50/medi-94-e145-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b162/4602834/f6319a2daba2/medi-94-e145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b162/4602834/3b944fd13b50/medi-94-e145-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b162/4602834/f6319a2daba2/medi-94-e145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b162/4602834/3b944fd13b50/medi-94-e145-g004.jpg

相似文献

1
Differential MIR-21 expression in plasma from mesenteric versus peripheral veins: an observational study of disease-free survival in surgically resected colon cancer patients.肠系膜静脉与外周静脉血浆中MIR-21的差异表达:一项关于手术切除结肠癌患者无病生存期的观察性研究
Medicine (Baltimore). 2015 Jan;94(1):e145. doi: 10.1097/MD.0000000000000145.
2
Exosomal microRNAs isolated from plasma of mesenteric veins linked to liver metastases in resected patients with colon cancer.从接受结肠癌切除术且伴有肝转移的患者肠系膜静脉血浆中分离出的外泌体微小RNA。
Oncotarget. 2017 May 9;8(19):30859-30869. doi: 10.18632/oncotarget.16103.
3
Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients.肿瘤引流静脉与外周静脉血浆和外泌体中 miR-200 家族成员对结肠癌患者预后的影响。
Oncology. 2018;95(5):309-318. doi: 10.1159/000490726. Epub 2018 Aug 23.
4
Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.血浆miR-183可预测结直肠癌患者的复发和预后。
Cancer Biol Ther. 2015;16(2):268-75. doi: 10.1080/15384047.2014.1002327.
5
Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse.miR-21在T3-4a期结直肠癌中的基质表达是早期肿瘤复发的独立预测指标。
BMC Gastroenterol. 2015 Jan 22;15:2. doi: 10.1186/s12876-015-0227-0.
6
Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.识别高危II期结肠癌患者:基于三种 microRNA 的评分作为预后生物标志物
Clin Colorectal Cancer. 2016 Dec;15(4):e175-e182. doi: 10.1016/j.clcc.2016.04.008. Epub 2016 May 7.
7
Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.利用失调的基质和上皮微小RNA对II期结直肠癌复发风险进行分层
Oncotarget. 2015 Mar 30;6(9):7262-79. doi: 10.18632/oncotarget.3225.
8
Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer.长链非编码RNA Fer-1样蛋白4通过与结肠癌中的miR-106a-5p结合来抑制肿瘤发生并具有预后价值。
Cancer Sci. 2015 Oct;106(10):1323-32. doi: 10.1111/cas.12759. Epub 2015 Sep 21.
9
Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.循环外泌体 miR-125a-3p 作为早期结肠癌的新型生物标志物。
Sci Rep. 2017 Jun 23;7(1):4150. doi: 10.1038/s41598-017-04386-1.
10
Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.血浆miR-122和miR-200家族是结直肠癌的预后标志物。
Int J Cancer. 2017 Jan 1;140(1):176-187. doi: 10.1002/ijc.30433. Epub 2016 Oct 3.

引用本文的文献

1
Endovascular image-guided sampling of tumor-draining veins provides an enriched source of oncological biomarkers.血管内图像引导下对肿瘤引流静脉进行采样可提供丰富的肿瘤生物标志物来源。
Front Oncol. 2023 Mar 17;13:916196. doi: 10.3389/fonc.2023.916196. eCollection 2023.
2
Prognostic value of microRNAs in colorectal cancer: a meta-analysis.微小RNA在结直肠癌中的预后价值:一项荟萃分析。
Cancer Manag Res. 2018 Apr 30;10:907-929. doi: 10.2147/CMAR.S157493. eCollection 2018.
3
Proteomic Analysis of Liquid Biopsy from Tumor-Draining Vein Indicates that High Expression of Exosomal ECM1 Is Associated with Relapse in Stage I-III Colon Cancer.

本文引用的文献

1
Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN).乙型肝炎病毒通过靶向程序性细胞死亡蛋白4(PDCD4)和磷酸酶及张力蛋白同源物(PTEN),经由HBx诱导的微小RNA-21在肝细胞癌中诱导细胞增殖。
PLoS One. 2014 Mar 14;9(3):e91745. doi: 10.1371/journal.pone.0091745. eCollection 2014.
2
Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer.结直肠癌循环肿瘤细胞的免疫逃逸和生存机制。
Cancer Res. 2014 Mar 15;74(6):1694-704. doi: 10.1158/0008-5472.CAN-13-1885. Epub 2014 Mar 5.
3
肿瘤引流静脉液体活检的蛋白质组学分析表明,外泌体ECM1的高表达与I-III期结肠癌复发相关。
Transl Oncol. 2018 Jun;11(3):715-721. doi: 10.1016/j.tranon.2018.03.010. Epub 2018 Apr 13.
4
Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer.循环微小RNA作为结直肠癌患者的预后和预测生物标志物
Noncoding RNA. 2016 Jun 1;2(2):5. doi: 10.3390/ncrna2020005.
5
Exosomal microRNAs isolated from plasma of mesenteric veins linked to liver metastases in resected patients with colon cancer.从接受结肠癌切除术且伴有肝转移的患者肠系膜静脉血浆中分离出的外泌体微小RNA。
Oncotarget. 2017 May 9;8(19):30859-30869. doi: 10.18632/oncotarget.16103.
6
New trends in molecular and cellular biomarker discovery for colorectal cancer.结直肠癌分子和细胞生物标志物发现的新趋势
World J Gastroenterol. 2016 Jul 7;22(25):5678-93. doi: 10.3748/wjg.v22.i25.5678.
7
MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer.微小RNA作为生长调节因子,其在结直肠癌中的功能及生物标志物地位
Oncotarget. 2016 Feb 9;7(6):6476-505. doi: 10.18632/oncotarget.6390.
8
Non-coding landscapes of colorectal cancer.结直肠癌的非编码图谱
World J Gastroenterol. 2015 Nov 7;21(41):11709-39. doi: 10.3748/wjg.v21.i41.11709.
9
MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.微小RNA-21可预测局部晚期直肠癌对术前放化疗的反应。
Int J Colorectal Dis. 2015 Jul;30(7):899-906. doi: 10.1007/s00384-015-2231-9. Epub 2015 May 8.
10
Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.微小RNA在乳头状肾细胞癌中的表达谱及临床意义:一项符合STROBE标准的观察性研究
Medicine (Baltimore). 2015 Apr;94(16):e767. doi: 10.1097/MD.0000000000000767.
Clinical relevance of circulating cell-free microRNAs in cancer.
循环细胞游离 microRNAs 在癌症中的临床相关性。
Nat Rev Clin Oncol. 2014 Mar;11(3):145-56. doi: 10.1038/nrclinonc.2014.5. Epub 2014 Feb 4.
4
Carcinoembryonic antigen levels in the peripheral and mesenteric venous blood of patients with rectal carcinoma.直肠癌患者外周血和肠系膜静脉血中癌胚抗原水平
Arq Gastroenterol. 2013 Oct-Dec;50(4):264-9. doi: 10.1590/S0004-28032013000400005.
5
Plasma post-operative miR-21 expression in the prognosis of gastric cancers.血浆术后miR-21表达在胃癌预后中的作用
Asian Pac J Cancer Prev. 2013;14(12):7551-4. doi: 10.7314/apjcp.2013.14.12.7551.
6
MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.微小RNA-21通过抑制丝裂原活化蛋白激酶激酶3促进肝癌HepG2细胞增殖。
BMC Cancer. 2013 Oct 10;13:469. doi: 10.1186/1471-2407-13-469.
7
Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.循环 miR-21 对癌症的诊断和预后价值:系统评价和荟萃分析。
Gene. 2014 Jan 1;533(1):389-97. doi: 10.1016/j.gene.2013.09.038. Epub 2013 Sep 26.
8
Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.血清 miR-21 作为结直肠癌的诊断和预后生物标志物。
J Natl Cancer Inst. 2013 Jun 19;105(12):849-59. doi: 10.1093/jnci/djt101. Epub 2013 May 23.
9
Vesicle trafficking and RNA transfer add complexity and connectivity to cell-cell communication.囊泡运输和 RNA 转移为细胞间通讯增添了复杂性和连通性。
Cancer Res. 2013 Jun 1;73(11):3200-5. doi: 10.1158/0008-5472.CAN-13-0265. Epub 2013 May 21.
10
The pre-metastatic niche: finding common ground.转移前生态位:寻找共同点。
Cancer Metastasis Rev. 2013 Dec;32(3-4):449-64. doi: 10.1007/s10555-013-9420-1.